You always want to know what the MTD is in any dose escalation study. The issue you want to avoid is not being able to explain to the FDA (or other regulators) why you stopped raising the dose if the side effect profile was manageable and higher doses are expected to work better. These days you need to justify scientifically to the regulators why you chose the dose level you did for Phase 2 - the RP2D (recommended phase 2 dose).
Having said this moving to multiple doses and then assessing the toxicity profile is the way to go. If at the end of 4 cycles at the 12GBq dose level the side effects are still below the tolerability limit then you can add on more patients at a higher dose until you get to MTD. CU6 have already shown a willingness to change the trial design as it is running based on results so I can't see why they would not add in another cohort at a higher dose level if 4 cycles is tolerated easily.
My one fear about the upcoming Phase 3 trial is Cu67SAR-bisPMSA being forced to be trialed in patients who have failed current Lu177 or Ac225 PMSA therapies. CU6 have been treated very well by the FDA to date so I am hopeful that they don't have to go down this path, but until we see the Phase 3 trial design it is a risk.
- Forums
- ASX - By Stock
- Ann: Theranostic prostate cancer trial advances to multi-dose
You always want to know what the MTD is in any dose escalation...
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.09 |
Change
-0.210(4.88%) |
Mkt cap ! $1.272B |
Open | High | Low | Value | Volume |
$4.30 | $4.30 | $4.08 | $3.493M | 835.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7459 | $4.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.12 | 9361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7459 | 4.090 |
1 | 2450 | 4.080 |
3 | 2089 | 4.070 |
1 | 10000 | 4.060 |
3 | 7617 | 4.050 |
Price($) | Vol. | No. |
---|---|---|
4.120 | 9361 | 1 |
4.160 | 10000 | 1 |
4.170 | 15000 | 1 |
4.190 | 600 | 1 |
4.240 | 1500 | 1 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$4.10 |
  |
Change
-0.210 ( 4.15 %) |
|||
Open | High | Low | Volume | ||
$4.17 | $4.29 | $4.08 | 50363 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
ATC
ALTECH BATTERIES LTD
Martin Stein, CFO
Martin Stein
CFO
Previous Video
Next Video
SPONSORED BY The Market Online